These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

714 related items for PubMed ID: 18809609

  • 21. A phase 2 clinical trial of nab-paclitaxel in previously treated and chemotherapy-naive patients with metastatic melanoma.
    Hersh EM, O'Day SJ, Ribas A, Samlowski WE, Gordon MS, Shechter DE, Clawson AA, Gonzalez R.
    Cancer; 2010 Jan 01; 116(1):155-63. PubMed ID: 19877111
    [Abstract] [Full Text] [Related]

  • 22. Prospective evaluations of continuous weekly paclitaxel regimen in recurrent platinum-resistant epithelial ovarian cancer.
    Le T, Hopkins L, Baines KA, Rambout L, Al Hayki M, Kee Fung MF.
    Gynecol Oncol; 2006 Jul 01; 102(1):49-53. PubMed ID: 16375951
    [Abstract] [Full Text] [Related]

  • 23. Phase II study of weekly albumin-bound paclitaxel for patients with metastatic breast cancer heavily pretreated with taxanes.
    Blum JL, Savin MA, Edelman G, Pippen JE, Robert NJ, Geister BV, Kirby RL, Clawson A, O'Shaughnessy JA.
    Clin Breast Cancer; 2007 Dec 01; 7(11):850-6. PubMed ID: 18269774
    [Abstract] [Full Text] [Related]

  • 24. A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer.
    Nakajo A, Hokita S, Ishigami S, Miyazono F, Etoh T, Hamanoue M, Maenohara S, Iwashita T, Komatsu H, Satoh K, Aridome K, Morita S, Natsugoe S, Takiuchi H, Nakano S, Maehara Y, Sakamoto J, Aikou T, Kyushu Taxol TS-1 Study Group.
    Cancer Chemother Pharmacol; 2008 Nov 01; 62(6):1103-9. PubMed ID: 18317763
    [Abstract] [Full Text] [Related]

  • 25. Phase I/II trial of weekly intravenous 130-nm albumin-bound paclitaxel as initial chemotherapy in patients with stage IV non-small-cell lung cancer.
    Rizvi NA, Riely GJ, Azzoli CG, Miller VA, Ng KK, Fiore J, Chia G, Brower M, Heelan R, Hawkins MJ, Kris MG.
    J Clin Oncol; 2008 Feb 01; 26(4):639-43. PubMed ID: 18235124
    [Abstract] [Full Text] [Related]

  • 26. A detailed evaluation of cardiac toxicity: a phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancer.
    Giordano SH, Booser DJ, Murray JL, Ibrahim NK, Rahman ZU, Valero V, Theriault RL, Rosales MF, Rivera E, Frye D, Ewer M, Ordonez NG, Buzdar AU, Hortobagyi GN.
    Clin Cancer Res; 2002 Nov 01; 8(11):3360-8. PubMed ID: 12429622
    [Abstract] [Full Text] [Related]

  • 27. A phase II study of weekly paclitaxel and epirubicin in recurrent or refractory squamous cell carcinoma of the head and neck.
    Wang TF, Chu SC, Kao RH, Yao CY, Li CC.
    Jpn J Clin Oncol; 2008 Jul 01; 38(7):459-63. PubMed ID: 18586668
    [Abstract] [Full Text] [Related]

  • 28. Weekly paclitaxel for platin-resistant stage IV head and neck cancer patients.
    Grau JJ, Caballero M, Verger E, Monzó M, Blanch JL.
    Acta Otolaryngol; 2009 Nov 01; 129(11):1294-9. PubMed ID: 19863327
    [Abstract] [Full Text] [Related]

  • 29. Weekly paclitaxel in women with heavily pretreated metastatic breast cancer: a retrospective analysis of cases treated at the Chang Gung Memorial Hospital.
    Lu CH, Lin YC, Chang HK.
    Chang Gung Med J; 2007 Nov 01; 30(1):33-40. PubMed ID: 17477027
    [Abstract] [Full Text] [Related]

  • 30. Phase I study of paclitaxel poliglumex administered weekly for patients with advanced solid malignancies.
    Mita M, Mita A, Sarantopoulos J, Takimoto CH, Rowinsky EK, Romero O, Angiuli P, Allievi C, Eisenfeld A, Verschraegen CF.
    Cancer Chemother Pharmacol; 2009 Jul 01; 64(2):287-95. PubMed ID: 19034451
    [Abstract] [Full Text] [Related]

  • 31. Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma.
    Safra T, Menczer J, Bernstein RM, Shpigel S, Matcejevsky D, Inbar MJ, Golan A, Grisaru D, Levy T.
    Gynecol Oncol; 2009 Aug 01; 114(2):215-8. PubMed ID: 19446318
    [Abstract] [Full Text] [Related]

  • 32. [Weekly paclitaxel administration in the adjuvant therapy of primary breast cancer].
    Takahashi H, Takahashi M, Taguchi K, Sasaki F, Todo S.
    Gan To Kagaku Ryoho; 2003 May 01; 30(5):653-9. PubMed ID: 12795097
    [Abstract] [Full Text] [Related]

  • 33. Experience in a UK cancer centre of weekly paclitaxel in the treatment of relapsed ovarian and primary peritoneal cancer.
    Linch M, Stavridi F, Hook J, Barbachano Y, Gore M, Kaye SB.
    Gynecol Oncol; 2008 Apr 01; 109(1):27-32. PubMed ID: 18262259
    [Abstract] [Full Text] [Related]

  • 34. Neoadjuvant paclitaxel for operable breast cancer: multicenter phase II trial with clinical outcomes.
    Kimura M, Sano M, Fujimori M, Nakagomi H, Negishi T, Yanagita Y, Sato N.
    Anticancer Res; 2008 Apr 01; 28(2B):1239-44. PubMed ID: 18505061
    [Abstract] [Full Text] [Related]

  • 35. [A phase II study of weekly paclitaxel for advanced or recurrent breast cancer].
    Wada Y, Otoshi M, Jitsuko A, Nishikawa H, Takahara S, Tsubono M, Imai S.
    Gan To Kagaku Ryoho; 2007 Jul 01; 34(7):1041-5. PubMed ID: 17637539
    [Abstract] [Full Text] [Related]

  • 36. Phase II study of oral vinorelbine in first-line advanced breast cancer chemotherapy.
    Freyer G, Delozier T, Lichinister M, Gedouin D, Bougnoux P, His P, Imadalou K, Trillet-Lenoir V.
    J Clin Oncol; 2003 Jan 01; 21(1):35-40. PubMed ID: 12506167
    [Abstract] [Full Text] [Related]

  • 37. Phase III trial of observation versus six courses of paclitaxel in patients with advanced epithelial ovarian cancer in complete response after six courses of paclitaxel/platinum-based chemotherapy: final results of the After-6 protocol 1.
    Pecorelli S, Favalli G, Gadducci A, Katsaros D, Panici PB, Carpi A, Scambia G, Ballardini M, Nanni O, Conte P, After 6 Italian Cooperative Group.
    J Clin Oncol; 2009 Oct 01; 27(28):4642-8. PubMed ID: 19704064
    [Abstract] [Full Text] [Related]

  • 38. A phase II study of weekly paclitaxel as second-line chemotherapy for advanced gastric Cancer (CCOG0302 study).
    Kodera Y, Ito S, Mochizuki Y, Fujitake S, Koshikawa K, Kanyama Y, Matsui T, Kojima H, Takase T, Ohashi N, Fujiwara M, Sakamoto J, Akimasa N, Chubu Clinical Cancer Group.
    Anticancer Res; 2007 Oct 01; 27(4C):2667-71. PubMed ID: 17695430
    [Abstract] [Full Text] [Related]

  • 39. A phase II study of carboplatin and paclitaxel for recurrent or metastatic head and neck cancer.
    Ferrari D, Fiore J, Codecà C, Di Maria G, Bozzoni S, Bordin V, Caldiera S, Luciani A, Zonato S, Floriani I, Foa P.
    Anticancer Drugs; 2009 Mar 01; 20(3):185-90. PubMed ID: 19396017
    [Abstract] [Full Text] [Related]

  • 40. Exatecan in pretreated adult patients with advanced soft tissue sarcoma: results of a phase II--study of the EORTC Soft Tissue and Bone Sarcoma Group.
    Reichardt P, Nielsen OS, Bauer S, Hartmann JT, Schöffski P, Christensen TB, Pink D, Daugaard S, Marreaud S, Van Glabbeke M, Blay JY, EORTC Soft Tissue and Bone Sarcoma Group.
    Eur J Cancer; 2007 Apr 01; 43(6):1017-22. PubMed ID: 17336054
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.